University of Seville / Universidad de Sevilla

Developing a bioactive glass coated dental floss: antibacterial and mechanical evaluations (2023) Simila H, Beltrán AM, Boccaccini AR Journal article Growth of hydroxyapatite plate-like nanoparticles by additive free precipitation for the deposition of aligned coatings (2023) Baştan FE, Şen B, Özgenç Ş, Beltrán AM, Boccaccini AR Journal article All-trans retinoic acid works synergistically with the γsecretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells (2023) Garcia-Guerrero E, Rodriguez-Lobato LG, Sierro-Martinez B, Danhof S, Bates S, Frenz S, Haertle L, et al. Journal article Treatment of pulpal and apical disease: The European Society of Endodontology (ESE) S3-level clinical practice guideline (2023) Duncan HF, Kirkevang LL, Peters OA, El-Karim I, Krastl G, Del Fabbro M, Chong BS, et al. Journal article Quaternary and pentanar mesoporous bioactive glass nanoparticles as novel nanocarriers for gallic acid: Characterisation, drug release and antibacterial activity (2023) Damian-Buda AI, Nawaz Q, Ünalan I, Beltrán AM, Boccaccini AR Journal article Mussel-Inspired Polydopamine Composite Mesoporous Bioactive Glass Nanoparticles: An Exploration of Potential Metal-Ion Loading Platform and In Vitro Bioactivity (2023) Sui B, Xu Z, Xue Z, Xiang Y, Zhou T, Beltrán AM, Zheng K, et al. Journal article Thermal and tribo-mechanical properties of high-performance poly(etheretherketone)/reduced graphene oxide nanocomposite coatings prepared by electrophoretic deposition (2023) González Castillo EI, Torres Y, González FJ, Aguilar Rabiela AE, Shuttleworth PS, Ellis GJ, Boccaccini AR Journal article Effect of Boron-Doped Mesoporous Bioactive Glass Nanoparticles on C2C12 Cell Viability and Differentiation: Potential for Muscle Tissue Application (2022) Ege D, Nawaz Q, Beltran AM, Boccaccini AR Journal article Influence of Copper-Strontium Co-Doping on Bioactivity, Cytotoxicity and Antibacterial Activity of Mesoporous Bioactive Glass (2022) Anand A, Sengupta S, Kankova H, Svancarkova A, Beltran AM, Galusek D, Boccaccini AR, Galuskova D Journal article Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysis (2022) Rodriguez-Arboli E, Labopin M, Eder M, Brecht A, Blau IW, Huynh A, Forcade E, et al. Journal article